| 5683- | BML, | Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway |
| - | in-vitro, | NA, | NA |
| 5685- | BML, | The Therapeutic Effects of Bromelain against Colorectal Cancer: A Systematic Review |
| - | Review, | CRC, | NA |
| 5649- | BNL, | Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood–brain barrier permeability |
| - | Review, | Nor, | NA |
| 5650- | BNL, | Borneol Depresses P-Glycoprotein Function by a NF-κB Signaling Mediated Mechanism in a Blood Brain Barrier in Vitro Model |
| - | in-vivo, | Nor, | NA |
| 5656- | BNL, | Role of borneol as enhancer in drug formulation: A review |
| - | Review, | Nor, | NA | - | Review, | Stroke, | NA | - | Review, | AD, | NA |
| 5651- | BNL, | Cisplatin, | Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway |
| - | in-vitro, | GBM, | U251 | - | in-vitro, | GBM, | U87MG |
| 5652- | BNL, | Borneol promotes apoptosis of Human Glioma Cells through regulating HIF-1a expression via mTORC1/eIF4E pathway |
| - | vitro+vivo, | GBM, | NA |
| 5653- | BNL, | Borneol hinders the proliferation and induces apoptosis through the suppression of reactive oxygen species-mediated JAK1 and STAT-3 signaling in human prostate cancer cells |
| - | in-vitro, | Pca, | PC3 |
| 5654- | BNL, | Pharmacokinetics of natural borneol after oral administration in mice brain and its effect on excitation ratio |
| - | in-vivo, | Nor, | NA |
| 5655- | BNL, | Comparative pharmacokinetic studies of borneol in mouse plasma and brain by different administrations |
| - | in-vivo, | Nor, | NA |
| 5657- | BNL, | Enhancing effect and safety assessment of borneol on the oral absorption of sub-100 nm PLGA nanoparticles |
| - | in-vivo, | Nor, | NA |
| - | vitro+vivo, | GBM, | U251 |
| 5659- | BNL, | Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood–brain barrier permeability: a preclinical systematic review and meta-analysis |
| - | Review, | Var, | NA |
| 5660- | BNL, | Recent Progress on the Synergistic Antitumor Effect of a Borneol-Modified Nanocarrier Drug Delivery System |
| - | Review, | Var, | NA |
| 5661- | BNL, | A clinical and mechanistic study of topical borneol‐induced analgesia |
| - | Trial, | Nor, | NA |
| 5662- | BNL, | Rad, | Role of Borneol Induced Autophagy in Enhancing Radiosensitivity of Malignant Glioma |
| - | vitro+vivo, | GBM, | NA |
| 5663- | BNL, | Osthole/borneol thermosensitive gel via intranasal administration enhances intracerebral bioavailability to improve cognitive impairment in APP/PS1 transgenic mice |
| - | in-vivo, | AD, | NA |
| 5664- | BNL, | Enhancing effect of natural borneol on the absorption of geniposide in rat via intranasal administration |
| - | in-vivo, | Nor, | NA |
| 5665- | BNL, | Enhancing both oral bioavailability and brain penetration of puerarin using borneol in combination with preparation technologies |
| - | in-vivo, | Nor, | NA |
| 5666- | BNL, | Exploring the potential to enhance drug distribution in the brain subregion via intranasal delivery of nanoemulsion in combination with borneol as a guider |
| - | in-vivo, | AD, | NA |
| 5667- | BNL, | Preparation and evaluation of sustained-release solid dispersions co-loading gastrodin with borneol as an oral brain-targeting enhancer |
| - | in-vivo, | Nor, | NA |
| 5668- | BNL, | Anticancer effect of borneol: Mechanistic insights through literature review and in silico studies |
| - | Review, | Var, | NA |
| 5669- | BNL, | Comparison of pharmacological activity and safety of different stereochemical configurations of borneol: L-borneol, D-borneol, and synthetic borneol |
| - | Review, | Nor, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
| 5670- | BNL, | Advances and perspectives on pharmacological activities and mechanisms of the monoterpene borneol |
| - | Review, | Stroke, | NA |
| 5671- | BNL, | (+)-Borneol inhibits the generation of reactive oxygen species and neutrophil extracellular traps induced by phorbol-12-myristate-13-acetate |
| - | in-vitro, | Nor, | NA |
| 5672- | Bor, | A comparative review of the pharmacokinetics of boric acid in rodents and humans |
| - | in-vivo, | Nor, | NA |
| 5673- | Bor, | Calcium Fructoborate Prevents Skin Cancer Development in Balb-c Mice |
| - | in-vivo, | Nor, | NA |
| 4272- | Bor, | Neuroprotective properties of borax against aluminum hydroxide-induced neurotoxicity: Possible role of Nrf-2/BDNF/AChE pathways in fish brain |
| 4271- | Bor, | Effects of Boron on Learning and Behavioral Disorders in Rat Autism Model Induced by Intracerebroventricular Propionic Acid |
| - | in-vivo, | NA, | NA |
| 4620- | Bor, | BTZ, | Boron Compounds in the Breast Cancer Cells Chemoprevention and Chemotherapy |
| - | Review, | Var, | NA | - | Review, | Arthritis, | NA | - | Review, | Pca, | NA |
| 4619- | Bor, | Using Boron Supplementation in Cancer Prevention and Treatment: A Review Article |
| - | Review, | Var, | NA |
| 4621- | Bor, | Boron |
| - | Review, | BPH, | NA |
| 4625- | Bor, | Boron and Inflammation |
| - | Review, | Arthritis, | NA | - | Review, | ostP, | NA |
| 4624- | Bor, | VitD3, | Boron as a Medicinal Ingredient in Oral Natural Health Products |
| - | Review, | Pca, | NA |
| 4623- | Bor, | Proteomic insights into the anti-cancer mechanisms of boron-based compounds in prostate cancer |
| - | Review, | Pca, | NA |
| 4622- | Bor, | Boron Level in the Prostate of the Normal Human: A Systematic Review |
| - | Review, | BPH, | NA |
| 696- | Bor, | Nothing Boring About Boron |
| - | Review, | Var, | NA |
| 697- | Bor, | Boron-containing compounds as preventive and chemotherapeutic agents for cancer |
| - | Review, | NA, | NA |
| 698- | Bor, | Boron deprivation decreases liver S-adenosylmethionine and spermidine and increases plasma homocysteine and cysteine in rats |
| - | in-vitro, | NA, | NA |
| 699- | Bor, | Boric Acid Alleviates Gastric Ulcer by Regulating Oxidative Stress and Inflammation-Related Multiple Signaling Pathways |
| - | in-vivo, | NA, | NA |
| 700- | Bor, | Diadenosine phosphates and S-adenosylmethionine: novel boron binding biomolecules detected by capillary electrophoresis |
| - | Analysis, | NA, | NA |
| 701- | Bor, | Dietary boron intake and prostate cancer risk |
| - | Analysis, | NA, | NA |
| 702- | Bor, | GEN, | SeMet, | Rad, | Evaluation of ecological and in vitro effects of boron on prostate cancer risk (United States) |
| - | Analysis, | NA, | NA |
| 703- | Bor, | Boron intake and prostate cancer risk |
| - | Analysis, | NA, | NA |
| 704- | Bor, | Inhibition of the enzymatic activity of prostate-specific antigen by boric acid and 3-nitrophenyl boronic acid |
| - | in-vitro, | Pca, | NA |
| 705- | Bor, | Boric acid inhibits human prostate cancer cell proliferation |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | LNCaP |
| 754- | Bor, | HRT, | Dietary Boron and Hormone Replacement Therapy as Risk Factors for Lung Cancer in Women |
| - | Analysis, | NA, | NA |
| 739- | Bor, | Borax regulates iron chaperone- and autophagy-mediated ferroptosis pathway in glioblastoma cells |
| - | in-vitro, | GBM, | U87MG | - | in-vitro, | Nor, | HMC3 |
| 740- | Bor, | Anti-cancer effect of boron derivatives on small-cell lung cancer |
| - | in-vitro, | Lung, | DMS114 | - | in-vitro, | Nor, | MRC-5 |
| 741- | Bor, | Boron Derivatives Inhibit the Proliferation of Breast Cancer Cells and Affect Tumor-Specific T Cell Activity In Vitro by Distinct Mechanisms |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid